These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [HIV protease inhibitors. A new drug class in antiretroviral therapy]. Mauss S; Seidlitz B; Jablonowski H; Häussinger D Dtsch Med Wochenschr; 1996 Nov; 121(44):1369-74. PubMed ID: 8964223 [No Abstract] [Full Text] [Related]
3. Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination. Lallemand F; Adda N; Schneider V; Jacomet C; Salhi Y; Rozenbaum W Clin Infect Dis; 1999 May; 28(5):1184-5. PubMed ID: 10452672 [No Abstract] [Full Text] [Related]
4. The choice of HIV protease inhibitor: indinavir is currently the best option. Prescrire Int; 1999 Apr; 8(40):55-60. PubMed ID: 10848067 [TBL] [Abstract][Full Text] [Related]
5. Viramune cleared for use in combination with protease inhibitors. AIDS Patient Care STDS; 1998 Nov; 12(11):872. PubMed ID: 11362046 [No Abstract] [Full Text] [Related]
6. Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS. Klaus BD; Grodesky MJ Nurse Pract; 1998 Feb; 23(2):102-4, 106. PubMed ID: 9513221 [No Abstract] [Full Text] [Related]
7. Development of HIV protease inhibitors: a survey. Ren S; Lien EJ Prog Drug Res; 1998; 51():1-31. PubMed ID: 9949858 [TBL] [Abstract][Full Text] [Related]
8. What they say about protease inhibitors. Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522 [TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy and clinical trials: what now? Lange JM; Richman DD Antivir Ther; 1996 Apr; 1(2):69-70. PubMed ID: 11321181 [No Abstract] [Full Text] [Related]
10. A patient's guide to protease inhibitors. Elperin A; Sax P AIDS Clin Care; 1996 Oct; 8(10):83-4. PubMed ID: 11363988 [TBL] [Abstract][Full Text] [Related]
11. Hyperlipidemia associated with the use of protease inhibitors. Smith JH; Martin GJ; Decker CF Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432 [No Abstract] [Full Text] [Related]
12. [FPV plus SQV plus a mini-dose ritonavir. "Double boosting with compatible partners]. MMW Fortschr Med; 2004 Apr; 146 Spec No 1():92-3. PubMed ID: 15373070 [No Abstract] [Full Text] [Related]
13. Virological treatment failure of highly active antiretroviral therapy in an unselected cohort of HIV-infected patients. Bonfanti P; Capetti A; Di Mattei P; Niero F; Rizzardini G AIDS; 1998 Jun; 12(9):1111. PubMed ID: 9662213 [No Abstract] [Full Text] [Related]
14. Ritonavir and indinavir one year later. TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094 [No Abstract] [Full Text] [Related]
15. Influence of indinavir and ritonavir on warfarin anticoagulant activity. Gatti G; Alessandrini A; Camera M; Di Biagio A; Bassetti M; Rizzo F AIDS; 1998 May; 12(7):825-6. PubMed ID: 9619821 [No Abstract] [Full Text] [Related]
16. Data in from first head-to-head protease inhibitor. AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961 [No Abstract] [Full Text] [Related]
17. Risk factors for ritonavir intolerance and outcome after change to indinavir. Casado JL; Perez-Elías MJ; Antela A; Martí-Belda P; de Lucas S; Muñoz V; Guerrero A AIDS; 1998 Feb; 12(3):335-6. PubMed ID: 9580044 [No Abstract] [Full Text] [Related]
18. Using ritonavir with indinavir in cases of virologic failure. TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095 [No Abstract] [Full Text] [Related]
19. Double protease inhibitor regimens with amprenavir show promise. AIDS Patient Care STDS; 1998 Apr; 12(4):317-8. PubMed ID: 11361962 [No Abstract] [Full Text] [Related]
20. [Clinical application of HIV protease inhibitors]. Chiba N; Shintani M; Ueno T; Hayashi H Tanpakushitsu Kakusan Koso; 1998 May; 43(6):744-51. PubMed ID: 9612068 [No Abstract] [Full Text] [Related] [Next] [New Search]